Strategic groups and platforms
Strategic groups
The main scientific activities of the Network take place within three strategic groups (RS) and three platforms. Each RS includes researchers (regular) from the three research domains and the eight universities, as well as associate members.

The three platforms support the strategic groups all while pursuing a mission of innovation. These platforms are focused on cross-cutting issues that affect the RS, their clienteles, care settings and contexts in which the care takes place.

Strategic groups

For regular researcher list with their strategic groups, please click here.


The main scientific activities of the Network take place within three strategic groups (SG) and three platforms.

The RS include (regular) researchers from the three research sectors and all partner universities, as well as associate members.
 

Strategic Group 1: Chronic Disease Management and End of Life Care

Leaders: José Côté and Christine Maheu

SG 1 has the mandate to develop, implement, evaluate and disseminate interventions in clinical care, organization, training and education to ensure better care and services to individuals / families living with chronic illness or who require end of life care, and in order to improve their health and quality of life.

This group is divided into two subgroups:

  1. Communication and Information Technology in Care
  2. Innovative Patient and Family Care Intervention

Strategic Group 2: Accessibility, Continuity and Safety in Care

Leaders: Geneviève Roch and Maud-Christine Chouinard

This SG's research program helps to articulate a set of projects that directly affect three thematic priorities set by the MSSS:
a) The strengthening of primary healthcare;
b) The improvement of the management of patients with multiple chronic diseases;
c) The improvement of the access to care, quality of service and safety for users at all levels of the network.

This group is divided into two subgroups:

  1. Primary Care
  2. Transitions between Sectors of Care

Strategic Group 3: Personalized Care

Leaders: Céline Gélinas and Marilyn Aita

SG 3 has the mandate to promote research on the development of personalized care interventions - based on the interpretation of behavior, assessment of symptoms or other - by teaching, organizational or clinicals strategies and by integrating these interventions for professional as well as assess the impact on patients and families vulnerable practices.

This group is divided into two subgroups:

  1. Humanistic Care and Vulnerable Persons
  2. Symptom Evaluation and Management